Temporal Dynamics of TNF-α Expression and Cell Viability in LPS-Stimulated Peripheral Blood Mononuclear Cells
Abstract
Background: Lipopolysaccharide (LPS), a key component of Gram-negative bacterial membranes, activates innate immune responses through Toll-like receptor 4 (TLR4) signaling in peripheral blood mononuclear cells (PBMCs). This study aimed to evaluate the temporal dynamics of TNF-α expression and cell viability in LPS-stimulated PBMCs to understand the inflammatory and cytotoxic effects of prolonged LPS exposure. Methods: Human PBMCs were treated with increasing concentrations of LPS (10, 30, and 50 ng/mL) for 4, 8, 12, and 24 hours. TNF-α mRNA expression was analyzed using quantitative PCR, while cell viability was assessed via CCK-8 assay and microscopic imaging. Results: LPS stimulation induced a robust, dose-dependent upregulation of TNF-α expression, peaking at 4 hours and gradually declining over time. Concurrently, PBMC viability remained stable up to 12 hours post-stimulation but significantly decreased at 24 hours, particularly at higher LPS concentrations (30–50 ng/mL). Microscopic analysis revealed increased cellular aggregation and morphological changes consistent with immune activation and cytotoxic stress. Conclusion:
LPS triggers early TNF-α expression in PBMCs through TLR4-mediated activation of the NF-κB pathway. However, prolonged exposure to LPS results in decreased cell viability, likely due to sustained inflammatory signaling and oxidative stress. These findings provide insight into the dual-phase response of PBMCs to LPS and underscore the importance of tightly regulated inflammation in innate immunity.
References
Scott McComb, Aude Thiriot, Bassel Akache, Lakshmi Krishnan. 2019. Introdution to the Immune System. Immunoproteomics. Pp. 1-24. https://www.researchgate.net/publication/334777384_Introduction_to_the_Immune_System
Jean S. Marshall, Richard Warrington, Wade Watson and Harold L. Kim. 2018. An introduction to immunology and immunopathology. Allergy, Asthma & Clinical Immunology. Article. 14:(49).
Allen KN, Imperiali B. Structural and Mechanistic Themes in Glycoconjugate Biosynthesis at Membrane Interfaces. 2019. Curr Opin Struct Biol. 59: 81–90. doi:10.1016/j.sbi.2019.03.013.
Abrar Alfatni, Marianne Riou, Anne Laure Charles, Alain Meyer, Cindy Barnig, Emmanuel Andreas, Anne Lejay, Samy Talha, Bernard Geny. 2020. Peripheral Blood Mononuclear Cells and Platelets
Mitochondrial Dysfunction, Oxidative Stress, and
Circulating mtDNA in Cardiovascular Diseases. Journal of Clinical Medicine. 9:311.
Reikvam, D. H., Sandanger, Ø., Moe, M. C., & Brinchmann, J. E. (2023). Immunomodulation by mesenchymal stromal cells: Direct effects on activated PBMCs and T cells revealed by single-cell analysis. Frontiers in Immunology, 14, 1056263. https://doi.org/10.3389/fimmu.2023.1056263.
Masoumi, S., Alimohammadi, M., Soleimani, M., & Salimian, J. (2020). Priming of mesenchymal stem cells for enhanced interleukin-10 secretion via conditioned medium from lipopolysaccharide-activated peripheral blood mononuclear cells. Cell and Bioengineering Studies, 1(1), 1–8. https://doi.org/10.22034/cbs.2020.236981.1001
Mytych J, Romerowicz-Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol Vitr. 2017;42:1-9. doi:10.1016/J.TIV.2017.03.009.
Talepoor AG, Rastegari B, Kalani M, Doroudchi M. Decrease in the inflammatory cytokines of LPS-stimulated PBMCs of patients with atherosclerosis by a TLR-4 antagonist in the co-culture with HUVECs. Int Immunopharmacol. 2021;101:108295. doi:10.1016/J.INTIMP.2021.108295
Bryson TD, Ross J, Peterson E, Harding P. Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling. Prostaglandins Other Lipid Mediat. 2019;144. doi:10.1016/j.prostaglandins.2019.106349
Fang C, Wang L, Qiao J, et al. Differential regulation of lipopolysaccharide-induced IL-1β and TNF-α production in macrophages by palmitate via modulating TLR4 downstream signaling. Int Immunopharmacol. 2022;103:108456. doi:10.1016/J.INTIMP.2021.108456
Page MJ, Kell DB, Pretorius E. The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation. Chronic Stress. 2022;6. doi:10.1177/24705470221076390/ASSET/815F7E01-DD45-4109-B97A-AB7B34F08CF9/ASSETS/IMAGES/LARGE/10.1177_24705470221076390-FIG5.JPG
Charoensappakit A, Sae‑khow K, Vutthikraivit N, et al. Immune suppressive activities of low-density neutrophils in sepsis and potential use as a novel biomarker of sepsis-induced immune suppression. Sci Rep. 2025;15(1). doi:10.1038/S41598-025-92417-7
Kuzmich NN, Sivak K V., Chubarev VN, Porozov YB, Savateeva-Lyubimova TN, Peri F. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines. 2017;5(4). doi:10.3390/VACCINES5040034
Liu J, Kang R, Tang D. Lipopolysaccharide delivery systems in innate immunity. Trends Immunol. 2024;45(4):274-287. doi:10.1016/J.IT.2024.02.003
Mazgaeen L, Gurung P. Recent Advances in Lipopolysaccharide Recognition Systems. Published online 2020.
Saber S, Youssef ME, Sharaf H, et al. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats. Life Sci. 2021;270. doi:10.1016/j.lfs.2021.119123
Gao Y, Tu D, Yang R, Chu CH, Gao HM, Hong JS. Through reducing ROS production, IL-10 suppresses caspase-1-dependent IL-1β maturation, thereby preventing chronic neuroinflammation and neurodegeneration. Int J Mol Sci. 2020;21(2):1-15. doi:10.3390/ijms21020465
Omote K, Gohda T, Murakoshi M, et al. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Am J Physiol Renal Physiol. 2014;306(11). doi:10.1152/AJPRENAL.00509.2013
Copyright (c) 2025 International Journal of Cell and Biomedical Science

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.